Biomedical subjects
W H Daughaday
Publications and source records attributed to W H Daughaday.
Acromegaly--a stubborn therapeutic challenge.
Explore the source record for details and available documents.
Catecholamine inhibition of prolactin secretion by isolated rat adenohypophyses.
Explore the source record for details and available documents.
Incorporation of 35S-sulfate into rat cartilage explants in vitro. Effects of aging on responsiveness to stimulation by sulfation factor.
Explore the source record for details and available documents.
Diabetic ketosis. Serial plasma growth hormone concentrations during therapy.
Explore the source record for details and available documents.
Cirrhosis and diabetes. V. Serum human growth hormone levels in Laennec's cirrhosis.
Explore the source record for details and available documents.
Growth hormone assay in acromegaly, gigantism, dwarfism and hypopituitarism.
Explore the source record for details and available documents.
Ultrastructural, histologic and hormonal characterization of a prolactin-rich human pituitary tumor.
Explore the source record for details and available documents.
Regulation of growth hormone secretion in acromegaly.
Explore the source record for details and available documents.
Diabetic ketosis: elevated serum glutamic-oxaloacetic transaminase (SGOT) and other findings determined by multi-channel chemical analysis.
Explore the source record for details and available documents.
Insulin storage and release in rats bearing growth hormone secreting tumors.
Explore the source record for details and available documents.
Defective sulfation factor generation: a possible etiological link in dwarfism.
Explore the source record for details and available documents.
Growth hormone secretion during sleep.
Plasma growth hormone (GH), insulin, cortisol, and glucose were measured during sleep on 38 nights in eight young adults. Blood was drawn from an indwelling catheter at 30-min intervals; EEG and electrooculogram were recorded throughout the night. In seven subjects, a plasma GH peak (13-72 mmug/ml) lasting 1.5-3.5 hr appeared with the onset of deep sleep. Smaller GH peaks (6-14 mmug/ml) occasionally appeared during subsequent deep sleep phases. Peak GH secretion was delayed if the onset of sleep was delayed. Subjects who were awakened for 2-3 hr and allowed to return to sleep exhibited another peak of GH secretion (14-46 mmug/ml). Peak GH secretion was not correlated with changes in plasma glucose, insulin, and cortisol. The effects of 6-CNS-active drugs on sleep-related GH secretion were investigated. Imipramine (50 mg) completely abolished GH peaks in two of four subjects, whereas chlorpromazine (30 mg), phenobarbital (97 mg), diphenylhydantoin (90 mg), chlordiazepoxide (20 mg), and isocarboxazid (30 mg) did not inhibit GH peaks. Altered hypothalamic activity associated with initiation of sleep results in a major peak of growth hormone secretion unrelated to hypoglycemia or changes in cortisol and insulin secretion.
Radioimmunoassay of growth hormone in rats bearing somatotropin producing tumors.
Explore the source record for details and available documents.
Sulfation factor: studies of its removal from plasma and metabolic fate in cartilage.
Explore the source record for details and available documents.
Disturbances of pituitary function in central nervous system disease.
Explore the source record for details and available documents.
The diagnosis of hypersomatotropism in man.
Explore the source record for details and available documents.
Hypopituitarism with normal or increased height. Report of two cases, with measurement of plasma growth hormone levels.
Explore the source record for details and available documents.